MedTrace Logo

Randomized Study of Osseotite Certain Tapered Prevails vs. Osseotite Certain Tapered

NCT01529775 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2022-03-28

No results posted yet for this study

Summary

This study will demonstrate the benefits of platform switching design of the Osseotite dental implant.

Conditions

  • Partial Edentulism
  • Tooth Disease

Interventions

DEVICE

Osseotite Certain Tapered Prevail

Osseotite implant with platform switching feature

DEVICE

Osseotite Certain Tapered

Osseotite implant with non-platform switching feature

Sponsors & Collaborators

  • ZimVie

    lead INDUSTRY

Principal Investigators

  • Manuel Pavez, DDS · Universidad Finis Terrae

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01529775 on ClinicalTrials.gov